For the first time, Stanford University, under the auspices of its Biodesign program, will sponsor a hands-on workshop for entrepreneurs in the medical device sectors. START-UP assembled a group of industry leaders who will be among the participating faculty, including David Douglass and John Maroney of Delphi Ventures, Richard Ferrari and Jay Watkins of De Novo Ventures, Wilson Sonsini's Casey McGlynn, and Paul Yock, MD, of Stanford's department of bioengineering, to discuss the do's and don'ts of early-stage entrepreneurship.
By Stephen Levin
Current business school curriculums are replete with entrepreneurship programs for MBA candidates, and senior corporate officers can have their pick...
Join thousands of industry professionals who rely on Medtech Insight for daily insights
Already a subscriber?
Leaders of robotic systems companies Distalmotion, Neocis and Noah Medical discussed success metrics, competition and funding. Institutional investors are focusing on utilization, procedure rates and a clear path to profitability as the IPO window reopens, BTIG analyst Ryan Zimmerman said.
Dxcover sets up new Clinical Laboratory Improvement Amendments (CLIA) lab in Franklin, Tennessee.
Fallouh Healthcare has received £305,050 in grant funding from Innovate UK as part of the European Union’s Eureka Eurostars program. The company aims to detect cardiac tamponade, a condition that affects patients after heart surgery. Currently, there is no way to accurately diagnose the condition.
Flow Neuroscience's neuromodulation headset for the treatment of depression is approved and marketed in the EU. However, two years on, the company is still waiting for US FDA approval despite being assigned breakthrough device designation.
Legal experts warn, however, that new Mexican procurement rules are discriminatory and could be challenged in the courts.
It’s no secret that Marty Makary and Robert F. Kennedy Jr. have a different take on user fees, with Makary viewing them as a funding necessity and Kennedy as a corrupting influence. But will they find a way to strike a balance during the next MDUFA reauthorization talks so each can claim victory?
Flow Neuroscience's neuromodulation headset for the treatment of depression is approved and marketed in the EU. However, two years on, the company is still waiting for US FDA approval despite being assigned breakthrough device designation.
